Monitored issues related to pharmaceutical prices. Issues related to dialysis. Issues regarding the pharmaceutical supply chain. S. 2333, Pandemic and All-Hazards Preparedness and Response Act. H.R. 4421, the Preparing for All-Hazards and Pathogen Reauthorization Act. Monitored S. 866, American Innovation, and H.R. 3938, the Build It in America Act, and Jobs Act and issues related to the R&D tax credit. Issues related to ESRD. Monitored implementation of drug pricing provisions related to H.R. 5376 (P.L. 117-169), The Inflation Reduction Act. Issues related to safe mobility. Issues related to reimbursement for breakthrough devices.
HCR - Health Issues TAX - Taxation/Internal Revenue Code MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
BRETT BAKER MARY BETH SAVARY TAYLOR RACHEL JONES HENSLER BRETT BAKER GREG D'ANGELO MARY BETH SAVARY TAYLOR